322 related articles for article (PubMed ID: 25916068)
1. Tumor-to-muscle ratio of 8F-FDG PET for predicting histologic features and recurrence of HCC.
Baek YH; Lee SW; Jeong YJ; Jeong JS; Roh YH; Han SY
Hepatogastroenterology; 2015; 62(138):383-8. PubMed ID: 25916068
[TBL] [Abstract][Full Text] [Related]
2. Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
Cheung TT; Chan SC; Ho CL; Chok KS; Chan AC; Sharr WW; Ng KK; Poon RT; Lo CM; Fan ST
Liver Transpl; 2011 Oct; 17(10):1218-25. PubMed ID: 21688383
[TBL] [Abstract][Full Text] [Related]
3. A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
Fartoux L; Balogova S; Nataf V; Kerrou K; Huchet V; Rosmorduc O; Talbot JN
Nucl Med Commun; 2012 Jul; 33(7):757-65. PubMed ID: 22504293
[TBL] [Abstract][Full Text] [Related]
4. Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
Hsu CC; Chen CL; Wang CC; Lin CC; Yong CC; Wang SH; Liu YW; Lin TL; Lee WF; Lin YH; Chan YC; Wu YJ; Eng HL; Cheng YF
Transplantation; 2016 Sep; 100(9):1925-32. PubMed ID: 27306534
[TBL] [Abstract][Full Text] [Related]
5. A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma.
Wu TH; Hatano E; Yamanaka K; Seo S; Taura K; Yasuchika K; Fujimoto Y; Nitta T; Mizumoto M; Mori A; Okajima H; Kaido T; Uemoto S
Surg Today; 2016 Nov; 46(11):1275-81. PubMed ID: 26983710
[TBL] [Abstract][Full Text] [Related]
6. Preoperative prediction of microvascular invasion of hepatocellular carcinoma using
Hyun SH; Eo JS; Song BI; Lee JW; Na SJ; Hong IK; Oh JK; Chung YA; Kim TS; Yun M
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):720-726. PubMed ID: 29167923
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma.
Detry O; Govaerts L; Deroover A; Vandermeulen M; Meurisse N; Malenga S; Bletard N; Mbendi C; Lamproye A; Honoré P; Meunier P; Delwaide J; Hustinx R
World J Gastroenterol; 2015 Mar; 21(10):3049-54. PubMed ID: 25780305
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH
Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma.
Kobayashi T; Aikata H; Honda F; Nakano N; Nakamura Y; Hatooka M; Morio K; Morio R; Fukuhara T; Masaki K; Nagaoki Y; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Ohdan H; Awai K; Chayama K
J Comput Assist Tomogr; 2016; 40(4):524-30. PubMed ID: 26966955
[TBL] [Abstract][Full Text] [Related]
10. Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization.
Kim MJ; Kim YS; Cho YH; Jang HY; Song JY; Lee SH; Jeong SW; Kim SG; Jang JY; Kim HS; Kim BS; Lee WH; Park JM; Lee JM; Lee MH; Choi DL
Korean J Intern Med; 2015 May; 30(3):308-15. PubMed ID: 25995661
[TBL] [Abstract][Full Text] [Related]
11. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
Song JY; Lee YN; Kim YS; Kim SG; Jin SJ; Park JM; Choi GS; Chung JC; Lee MH; Cho YH; Choi MH; Kim DC; Choi HJ; Moon JH; Lee SH; Jeong SW; Jang JY; Kim HS; Kim BS
Nucl Med Commun; 2015 Apr; 36(4):319-27. PubMed ID: 25564069
[TBL] [Abstract][Full Text] [Related]
12. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
[TBL] [Abstract][Full Text] [Related]
13. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
[TBL] [Abstract][Full Text] [Related]
15. Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT.
Ahn SY; Lee JM; Joo I; Lee ES; Lee SJ; Cheon GJ; Han JK; Choi BI
Abdom Imaging; 2015 Apr; 40(4):843-51. PubMed ID: 25253426
[TBL] [Abstract][Full Text] [Related]
16. Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection.
Morio K; Kawaoka T; Aikata H; Namba M; Uchikawa S; Kodama K; Ohya K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Imamura M; Nakamura Y; Akagi M; Awai K; Kobayashi T; Ohdan H; Chayama K
Eur J Radiol; 2020 Mar; 124():108828. PubMed ID: 31955034
[TBL] [Abstract][Full Text] [Related]
17. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma: A prospective observational study.
Lim C; Salloum C; Chalaye J; Lahat E; Costentin CE; Osseis M; Itti E; Feray C; Azoulay D
HPB (Oxford); 2019 Jun; 21(6):739-747. PubMed ID: 30401520
[TBL] [Abstract][Full Text] [Related]
19. The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas.
Ahn SG; Kim SH; Jeon TJ; Cho HJ; Choi SB; Yun MJ; Lee JD; Kim KS
J Gastrointest Surg; 2011 Nov; 15(11):2044-52. PubMed ID: 21904962
[TBL] [Abstract][Full Text] [Related]
20. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.
Zhang W; Lai SL; Chen J; Xie D; Wu FX; Jin GQ; Su DK
World J Gastroenterol; 2017 Sep; 23(35):6467-6473. PubMed ID: 29085196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
